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Abstract
Introduction: Application of emollients is a widespread traditional newborn care practice in many low and
middle-income countries (LMICs) and may have the potential to decrease infection and consequent mortality in
preterm neonates.
Methods: We systematically reviewed literature published up to December 2012 to identify studies describing the
effectiveness of emollient therapy. We used a standardized abstraction and grading format to estimate the effect of
emollient therapy by applying the standard Child Health Epidemiology Reference Group (CHERG) rules.
Results: We included seven studies and one unpublished trial in this review. Topical emollient therapy significantly
reduced neonatal mortality by 27% (RR: 0.73, 95% CI: 0.56, 0.94) and hospital acquired infection by 50% (RR: 0.50,
95% CI: 0.36, 0.71). There were significant increases in weight (g) (MD: 98.04, 95% CI: 42.64, 153.45) and weight gain
(g/kg/day) (MD: 1.57, 95% CI: 0.79, 2.36), whereas the impacts were non-significant for length and head
circumference.
Conclusion: Emollient therapy is associated with improved weight gain, reduced risk of infection and associated
newborn mortality in preterm neonates and is a potentially promising intervention for use in low resource settings.
Large scale effectiveness trials are required to further assess the impact of this intervention.
Introduction
Neonatal mortality is increasingly important in order to
progress on the Millennium Development Goal (MDG)
for child survival by 2015 and beyond, as 40% of under-
five deaths occur in newborns and 14% of these are
attributable to preterm birth complications [1]. Despite
the progress in reducing under five mortality, advances
in addressing low birth weight (LBW) and prematurity
have been slow. Every year around 15 million babies are
born preterm, mostly in Africa and South Asia, and
over 1 million die due to complications of prematurity
[2]. The mortality rate among preterm neonates less
than 32 weeks gestational age in some developing coun-
tries is over 50% [3,4], and more than half of these
deaths are attributable to vulnerability to infections [5].
Moreover, there has been an increase in preterm birth
rates over the past 20 years [6].
Evidence suggests that compromised skin barrier func-
tion of preterm newborns serves as an important contri-
butor towards increased susceptibility to infections,
hence morbidity and mortality. The high prevalence of
malnutrition and environmental load of pathogenic
organisms in developing countries further enhances this
vulnerability. Newborn oil massage is an intervention
that has been a traditional practice in the Indian sub-
continent for hundreds of years [7-9] and this acts by
augmenting the mechanical barrier and also is a source
of essential fatty acids like linoleic acid [10]. It provides
a physical barrier to skin disruption, reduces micro-
organism invasion and consequently reduces hospital
acquired infections [11]. It also reduces transepidermal
water loss [12,13] and conserves heat and energy to
promote growth [14].
Mustard oil is the most commonly used emollient,
particularly in South Asia, but other natural plant oils
like sunflower, sesame, coconut, olive, and soybean oils
are also commonly available and used. Animal studies
have raised concern that mustard oil is much less effec-
tive at promoting and maintaining skin integrity than
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other emollients [15]. More recently there have been
studies suggesting the benefit of newborn massage on
brain development, stress reduction and reduced risk of
retinopathy of prematurity [16,17].
Despite the wide body of primary research on emollient
therapy there are few syntheses of the existing data. A
Cochrane review [18] on this subject only covered extre-
mely low birth weight infants from High Income Coun-
tries (HIC). Given the potential for topical emollient
therapy to prevent infection in preterm or low birth
weight infants in low and middle income countries
(LMICs), and the risks that this traditional practice may in
fact be harmful, in this review, we have estimated the
effect of topical emollient therapy on hospital acquired
infection, growth, mortality and other health outcomes
among hospitalized preterm infants. We have reviewed
the available literature and evaluated the quality of
included studies according to the Child Health Epidemi-
ology Group (CHERG) adaptation of Grading of Recom-
mendations, Assessments, Development and Education
(GRADE) criteria [19].
Methods
We systematically reviewed literature published up to
December 2012 to identify studies describing the effec-
tiveness of emollient therapy. Following CHERG Sys-
tematic Review Guidelines [19], we searched PubMed,
Cochrane Libraries, Embase, and WHO Regional Data-
bases to identify all published and unpublished clinical
trials. Additional studies were identified by hand search-
ing references from included studies. Search terms
included combinations of emollient* OR “emollient
therapy” OR “massage” OR skin care OR oils OR “plant
oils” OR “vegetable oils” OR “mineral oil” OR sunflower
OR safflower OR coconut OR soybean OR sesame OR
massage AND preterm* OR “low birth weight” OR
neonate* OR newborn OR LBW. No language or date
restrictions were applied in the searches.
Inclusion criteria
Studies evaluating prophylactic application of topical
emollient to preterm neonates (< 37 weeks gestation)
and starting within the first 96 hours after birth and
continued for at least one week thereafter were
included. Studies that included topical emollient versus
routine skin care or one topical oil (or a combination of
oils) versus another (or a combination of oils) were
included. We excluded studies examining the impact of
aquaphor, as these are mostly used in developed country
settings, or those that were conducted in HIC.
Abstraction, analysis and summary measure
We abstracted data describing study identifiers and con-
text, study design and limitations, intervention specifics
and outcome effects into a standardized abstraction
form for studies that met the final inclusion criteria as
detailed in the CHERG Systematic Review Guidelines
[19]. Outcomes of interest included mortality, hospital
acquired infections, skin condition, weight, length, head
circumference and neuro-developmental outcomes. Each
study was assessed and graded according to the CHERG
adaptation of the GRADE technique [19].
Quantitative data synthesis
We conducted a meta-analysis for individual studies and
pooled statistics were reported as the relative risk (RR)
for categorical variables and mean difference (MD) for
continuous variables between the experimental and
control groups with 95% confidence intervals (CI).
Mantel–Haenszel pooled relative risk and corresponding
95% confidence interval (CI) were reported or the
DerSimonian–Laird pooled relative risk and correspond-
ing 95% CI where there was an unexplained hetero-
geneity. All analyses were conducted using the software
Review Manager 5.1. Heterogeneity was quantified
by Chi2 and I2, which can be interpreted as the percen-
tage of the total variation between studies that is attri-
butable to heterogeneity rather than to chance; a low
p-value (less than 0.1) or a large chi-squared statistic
relative to its degree of freedom and I2 values greater
than 50% were taken as substantial and high heteroge-
neity. In situations of high heterogeneity, causes were
explored by sensitivity analysis and random effect
models were used.
We summarized the evidence by outcome, including
qualitative assessments of study quality and quantitative
measures, according to the standard guidelines. A grade
of “high”, “moderate”, “low” and “very low” was used for
grading the overall evidence indicating the strength of
an effect on specific health outcome according to the
CHERG Rules for Evidence Review [19].
Results
We identified 3210 titles from searches conducted in all
databases. After screening titles and abstracts, we
reviewed 27 papers for the identified outcome measures
of interest of which seven [11,14,20-24] papers were
selected for inclusion, which evaluated the impact
of topical emollient therapy versus no intervention or
control (Figure 1). We also included data from one
unpublished trial [25]. Included studies used sunflower,
coconut, soybean or mineral oil as emollients and all
were conducted in developing countries. Two studies
[11,21] included neonates < 33 weeks gestation, two
studies [20,23] included neonates < 34 weeks gestation,
three studies [14,22,25] included neonates <37 weeks
gestation while one study [24] included neonates <35
weeks gestation. Three studies [11,20,21] identified
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gestational age according to the Dubowitz and Ballard,
and on the basis of maternal dates while one study [25]
estimated from ultrasound records and Ballard scores at
admission, whereas the other studies have not reported
on the method (Table 1).
In Table 2, we report the quality assessment of studies
by outcomes. For neonatal mortality and morbidity,
findings were based on three studies; topical emollient
therapy significantly reduced neonatal mortality by 27%
(RR: 0.73, 95% CI: 0.56, 0.94) (Figure 2) and reduced
hospital acquired infections by 50% (RR: 0.50, 95%
CI: 0.36, 0.71) (Figure 3). For growth outcomes, data was
pooled for four studies; emollient therapy was associated
with significant increase in weight (MD: 98.04, 95%
CI: 42.64, 153.45) (Figure 4) and weight gain (g/kg/day)
(MD: 1.57, 95% CI: 0.79, 2.36). The impacts were
Figure 1 Search flow diagram
Table 1 Characteristics of the included studies
Author Country Target population Emollient Dose and frequency Follow up
Arora 2005 [14] India Neonates <37 weeks and <1500 g Sunflower
oil





Egypt Neonates <34 weeks and <72hr old. Gestational age was
determined with an average of gestational age values by




3 times a day for 14





Bangladesh Neonates <33 weeks and <72hr old. Gestational age was
identified by doctors, according to the methods described
by Dubowitz and Ballard, and on the basis of maternal
dates (time from the first day of the last menstrual period);






3 times a day for 14







Bangladesh Neonates <33 weeks and <72hr old. Gestational age was
identified by doctors, according to the methods described
by Dubowitz and Ballard, and on the basis of maternal
dates (time from the first day of the last menstrual period);






3 times a day for 14










Pakistan Neonates ≥26 weeks and ≤37 weeks with a birth weight
>750g. Gestational age estimated from ultrasound records
and Ballard scores at admission
Coconut
oil










4 times a day 31 days
Soriano 2000 [23] Brazil Neonates 28-34 weeks and <1700 g Soybean
oil
3 times a day (12g/kg/
day)
30 days
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non-significant for length (MD: 0.33, 95% CI: -0.15, 0.81)
and head circumference (MD: 0.05, 95% CI: -0.30, 0.41).
Recommendation for the LiST model
Of the outcomes assessed for effect of topical emollient
therapy among preterm newborns in developing coun-
tries, we applied the CHERG rules for evidence review to
these outcomes. We had data on mortality but since the
evidence was weak, we used hospital acquired infection
(severe morbidity) as a proxy for neonatal mortality and
propose that topical emollient therapy for preterm neo-
nates can reduce neonatal infection related mortality by
50% among preterm neonates <37 weeks gestation.
Discussion
In this systematic review we estimated the effect of topical
emollient therapy on preterm newborns in developing
countries. Trials were included that reported various
Table 2 Quality assessment by outcome
Quality assessment Summary of findings
Directness No of events*
No of
studies





Intervention Control RR / SMD
(95% CI)
Neonatal mortality: moderate outcome specific quality of evidence









Two of the studies used
sunflower while one used
coconut oil as emollient
04 11 RR: 0.73
[0.56,
0.94]
Hospital acquired infection: moderate outcome specific quality of evidence








Studies used sunflower and
coconut oil
19 33 RR: 0.50
[0.36,
0.71]


































Studies used coconut and
sunflower oil
95 97 SMD: 1.57
[0.79,
2.36]














Studies used coconut and
sunflower oil
124 128 SMD: 0.33
[-0.15,
0.81]














Studies used coconut and
sunflower oil
124 128 SMD: 0.05
[-0.30,
0.41]
Figure 2 Forest plot for the impact of emollient therapy on neonatal mortality
Salam et al. BMC Public Health 2013, 13(Suppl 3):S31
http://www.biomedcentral.com/1471-2458/13/S3/S31
Page 4 of 7
neonatal health outcomes including hospital acquired
infection, mortality and anthropometric indices. The
studies contributing data in this review were conducted
in developing countries including India, Pakistan, Bangla-
desh, Egypt and Brazil, hence increasing the generali-
zability of the studies to newborns in LMICs with the
highest neonatal mortality and infection rates. All the
studies evaluated the impact of topical emollient appli-
cation in facility settings among preterm neonates. Emolli-
ents used in the studies included sunflower, coconut,
soybean and mineral oil. The follow-up period ranged
from 28-31 days of life. Only one study reported the
follow-up till discharge [11].
Topical emollient therapy has been shown to reduce
mortality and hospital acquired infections significantly
and also improved weight. It was associated with a signi-
ficantly higher weight gain of 98g than in controls over
the first 28 days of life. However the impacts on length
and head circumference were non-significant. Neurode-
velopment outcomes were reported in only one study
and were found to be comparable in the intervention
and control group [14]. It is worthwhile to observe that
although the evidence is weak for neonatal mortality
due to the fewer number of events, the evidence comes
from good quality RCTs with no significant heterogeneity
reported in the pooled analysis.
The findings from this review contradict with the find-
ings from a published review which indicated increased
risk of hospital acquired infection with prophylactic appli-
cation of topical ointment in preterm neonates [18]. This
review differs from our review as it was from studies
conducted in HICs with most of the participants being
extremely LBW infants and the emollient most commonly
used in the trials was aquaphor ointment and most infec-
tions were due to coagulase-negative staphylococci. The
findings of the previous review cannot be generalized
to LMIC settings, as most infections in these settings are
due to gram-negative bacteria, for which the attributable
morbidity and mortality is much greater than that of
coagulase-negative staphylococcal infection [26,27]. Also
the commonly used emollients in these settings include
coconut, sunflower, almond and olive oil [28].
In this review we have shown that there is potential
for benefit of this traditional, simple, affordable, and
Figure 3 Forest plot for the impact of emollient therapy on hospital acquired infection
Figure 4 Forest plot for the impact of emollient on weight
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effective intervention. Efforts should now be concentrated
on its scale-up for delivery in hospitals in low-resource
settings to reduce neonatal mortality risk due to prematur-
ity and infections. There are no large scale community
based effectiveness trials to evaluate its pragmatic benefits
or otherwise in community settings. Studies are also
required to assess if this intervention is associated with
any adverse effects and to explore the benefits of various
emollients and to determine which ones are most effective.
Conclusion
Our analysis of the effect of topical emollient therapy
among preterm neonates in developing countries suggests
benefit in reducing hospital acquired infections and
mortality and improving weight in preterm neonates.
However, its implications and feasibility for community
scale-up needs to be explored.
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